Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer

January 25, 2011 By Bio-Medicine.Org

EAST BRUNSWICK, N.J., Jan. 25, 2011 /PRNewswire/ — Savient
Pharmaceuticals, Inc. (Nasdaq:
SVNT) today announced that its board of directors has named
John H. Johnson as Chief Executive Officer, effective January 31,
2011.  Mr. Johnson will also serve as a member of Savient’s
board of directors.

Mr. Johnson brings significant biotechnology business experience
to Savient.  Most recently, he served as a Senior Vice
President of Eli Lilly and Company and President of Lilly Oncology
Business Unit.  From August 2007 to November 2009, Mr. Johnson
was Chief Executive Officer of ImClone Systems, which develops
targeted biologic cancer treatments, and served on ImClone’s board
of directors until the company was acquired by Lilly in November
2008.  

“John is a seasoned and accomplished leader in the
biopharmaceutical industry and we are very fortunate to have him
join Savient as our CEO,” said Stephen O. Jaeger, Chairman of the
Board.  “With the depth of his industry experience, we believe
John is the right person to help Savient bring KRYSTEXXA™
(pegloticase) to market and realize this novel drug’s full
potential, both for our shareholders and those adult patients
suffering from chronic gout refractory to conventional therapy.
 Since securing FDA approval for KRYSTEXXA in September, we
have been focused on bringing this exciting new drug to market.
 John is ideally suited to move us the rest of the way down
the road.”

“I am thrilled to be joining Savient at this exciting time,”
said Mr. Johnson.  “KRYSTEXXA is a product that has potential
to make a significant difference in the lives of patients around
the world.  I look forward to working with the dedicated and
talented Savient employees to bring relief to those adult patients
suffering from chronic gout refractory to conventional
therapy.  My focus will be

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech